APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antibiotics

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Antibiotics Market Analysis and Forecast 2026-2032

20 December 2025194 pages

Choose your research edition.

Industry ResearchAntibiotics Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Antibiotics Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Antibiotics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antibiotics Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Antibiotics Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Antibiotics market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Antibiotics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Antibiotics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Antibiotics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Antibiotics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Antibiotics include Astellas Pharma, Bristol Myers Squibb Company, Janssen Pharmaceuticals, Bayer, GlaxoSmithKline, Pfizer, Eli Lilly and Company, Novartis and Sanofi, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Antibiotics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Antibiotics, also provides the sales of main regions and countries. Of the upcoming market potential for Antibiotics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antibiotics sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Antibiotics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Antibiotics sales, projected growth trends, production technology, application and end-user industry.

Antibiotics Segment by Company

Astellas Pharma

Bristol Myers Squibb Company

Janssen Pharmaceuticals

Bayer

GlaxoSmithKline

Pfizer

Eli Lilly and Company

Novartis

Sanofi

Abbott

Antibiotics Segment by Type

Cephalosporins

Macrolides

Sulfonamides

Others

Penicillins

Aminoglycosides

Tetracyclines

Antibiotics Segment by Application

Poultry

Livestock

Other

Antibiotics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antibiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antibiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antibiotics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Antibiotics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Antibiotics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antibiotics sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Antibiotics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Cephalosporins Major Manufacturers Table 3. Macrolides Major Manufacturers Table 4. Sulfonamides Major Manufacturers Table 5. Others Major Manufacturers Table 6. Penicillins Major Manufacturers Table 7. Aminoglycosides Major Manufacturers Table 8. Tetracyclines Major Manufacturers Table 9. Global Antibiotics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 10. Poultry Major Manufacturers Table 11. Livestock Major Manufacturers Table 12. Other Major Manufacturers Table 13. Antibiotics Industry Trends Table 14. Antibiotics Industry Drivers Table 15. Antibiotics Industry Opportunities and Challenges Table 16. Antibiotics Industry Restraints Table 17. Global Antibiotics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Antibiotics Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Antibiotics Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Antibiotics Revenue Market Share by Region (2021-2026) Table 21. Global Antibiotics Revenue Market Share by Region (2027-2032) Table 22. Global Antibiotics Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 23. Global Antibiotics Sales by Region (2021-2026) & (K Units) Table 24. Global Antibiotics Sales by Region (2027-2032) & (K Units) Table 25. Global Antibiotics Sales Market Share by Region (2021-2026) Table 26. Global Antibiotics Sales Market Share by Region (2027-2032) Table 27. Global Antibiotics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Antibiotics Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Antibiotics Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Antibiotics Sales Market Share by Manufacturers (2021-2026) Table 31. Global Antibiotics Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 32. Global Antibiotics Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Antibiotics Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Antibiotics Manufacturers, Product Type & Application Table 35. Global Antibiotics Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Antibiotics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Antibiotics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Antibiotics Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Antibiotics Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Antibiotics Revenue Market Share by Type (2021-2026) Table 42. Global Antibiotics Revenue Market Share by Type (2027-2032) Table 43. Global Antibiotics Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 44. Global Antibiotics Sales by Type (2021-2026) & (K Units) Table 45. Global Antibiotics Sales by Type (2027-2032) & (K Units) Table 46. Global Antibiotics Sales Market Share by Type (2021-2026) Table 47. Global Antibiotics Sales Market Share by Type (2027-2032) Table 48. Global Antibiotics Price by Type (2021-2026) & (US$/Unit) Table 49. Global Antibiotics Price by Type (2027-2032) & (US$/Unit) Table 50. Global Antibiotics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Antibiotics Revenue by Application (2021-2026) & (US$ Million) Table 52. Global Antibiotics Revenue by Application (2027-2032) & (US$ Million) Table 53. Global Antibiotics Revenue Market Share by Application (2021-2026) Table 54. Global Antibiotics Revenue Market Share by Application (2027-2032) Table 55. Global Antibiotics Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 56. Global Antibiotics Sales by Application (2021-2026) & (K Units) Table 57. Global Antibiotics Sales by Application (2027-2032) & (K Units) Table 58. Global Antibiotics Sales Market Share by Application (2021-2026) Table 59. Global Antibiotics Sales Market Share by Application (2027-2032) Table 60. Global Antibiotics Price by Application (2021-2026) & (US$/Unit) Table 61. Global Antibiotics Price by Application (2027-2032) & (US$/Unit) Table 62. Astellas Pharma Company Information Table 63. Astellas Pharma Business Overview Table 64. Astellas Pharma Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Astellas Pharma Antibiotics Product Portfolio Table 66. Astellas Pharma Recent Development Table 67. Bristol Myers Squibb Company Company Information Table 68. Bristol Myers Squibb Company Business Overview Table 69. Bristol Myers Squibb Company Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Bristol Myers Squibb Company Antibiotics Product Portfolio Table 71. Bristol Myers Squibb Company Recent Development Table 72. Janssen Pharmaceuticals Company Information Table 73. Janssen Pharmaceuticals Business Overview Table 74. Janssen Pharmaceuticals Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Janssen Pharmaceuticals Antibiotics Product Portfolio Table 76. Janssen Pharmaceuticals Recent Development Table 77. Bayer Company Information Table 78. Bayer Business Overview Table 79. Bayer Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Bayer Antibiotics Product Portfolio Table 81. Bayer Recent Development Table 82. GlaxoSmithKline Company Information Table 83. GlaxoSmithKline Business Overview Table 84. GlaxoSmithKline Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. GlaxoSmithKline Antibiotics Product Portfolio Table 86. GlaxoSmithKline Recent Development Table 87. Pfizer Company Information Table 88. Pfizer Business Overview Table 89. Pfizer Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Pfizer Antibiotics Product Portfolio Table 91. Pfizer Recent Development Table 92. Eli Lilly and Company Company Information Table 93. Eli Lilly and Company Business Overview Table 94. Eli Lilly and Company Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Eli Lilly and Company Antibiotics Product Portfolio Table 96. Eli Lilly and Company Recent Development Table 97. Novartis Company Information Table 98. Novartis Business Overview Table 99. Novartis Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Novartis Antibiotics Product Portfolio Table 101. Novartis Recent Development Table 102. Sanofi Company Information Table 103. Sanofi Business Overview Table 104. Sanofi Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Sanofi Antibiotics Product Portfolio Table 106. Sanofi Recent Development Table 107. Abbott Company Information Table 108. Abbott Business Overview Table 109. Abbott Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Abbott Antibiotics Product Portfolio Table 111. Abbott Recent Development Table 112. North America Antibiotics Revenue by Type (2021-2026) & (US$ Million) Table 113. North America Antibiotics Revenue by Type (2027-2032) & (US$ Million) Table 114. North America Antibiotics Sales by Type (2021-2026) & (K Units) Table 115. North America Antibiotics Sales by Type (2027-2032) & (K Units) Table 116. North America Antibiotics Sales Price by Type (2021-2026) & (US$/Unit) Table 117. North America Antibiotics Sales Price by Type (2027-2032) & (US$/Unit) Table 118. North America Antibiotics Revenue by Application (2021-2026) & (US$ Million) Table 119. North America Antibiotics Revenue by Application (2027-2032) & (US$ Million) Table 120. North America Antibiotics Sales by Application (2021-2026) & (K Units) Table 121. North America Antibiotics Sales by Application (2027-2032) & (K Units) Table 122. North America Antibiotics Sales Price by Application (2021-2026) & (US$/Unit) Table 123. North America Antibiotics Sales Price by Application (2027-2032) & (US$/Unit) Table 124. North America Antibiotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. North America Antibiotics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 126. North America Antibiotics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 127. North America Antibiotics Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 128. North America Antibiotics Sales by Country (2021-2026) & (K Units) Table 129. North America Antibiotics Sales by Country (2027-2032) & (K Units) Table 130. North America Antibiotics Sales Price by Country (2021-2026) & (US$/Unit) Table 131. North America Antibiotics Sales Price by Country (2027-2032) & (US$/Unit) Table 132. United States Antibiotics Revenue (2021-2032) & (US$ Million) Table 133. Canada Antibiotics Revenue (2021-2032) & (US$ Million) Table 134. Europe Antibiotics Revenue by Type (2021-2026) & (US$ Million) Table 135. Europe Antibiotics Revenue by Type (2027-2032) & (US$ Million) Table 136. Europe Antibiotics Sales by Type (2021-2026) & (K Units) Table 137. Europe Antibiotics Sales by Type (2027-2032) & (K Units) Table 138. Europe Antibiotics Sales Price by Type (2021-2026) & (US$/Unit) Table 139. Europe Antibiotics Sales Price by Type (2027-2032) & (US$/Unit) Table 140. Europe Antibiotics Revenue by Application (2021-2026) & (US$ Million) Table 141. Europe Antibiotics Revenue by Application (2027-2032) & (US$ Million) Table 142. Europe Antibiotics Sales by Application (2021-2026) & (K Units) Table 143. Europe Antibiotics Sales by Application (2027-2032) & (K Units) Table 144. Europe Antibiotics Sales Price by Application (2021-2026) & (US$/Unit) Table 145. Europe Antibiotics Sales Price by Application (2027-2032) & (US$/Unit) Table 146. Europe Antibiotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Europe Antibiotics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 148. Europe Antibiotics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 149. Europe Antibiotics Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 150. Europe Antibiotics Sales by Country (2021-2026) & (K Units) Table 151. Europe Antibiotics Sales by Country (2027-2032) & (K Units) Table 152. Europe Antibiotics Sales Price by Country (2021-2026) & (US$/Unit) Table 153. Europe Antibiotics Sales Price by Country (2027-2032) & (US$/Unit) Table 154. Germany Antibiotics Revenue (2021-2032) & (US$ Million) Table 155. France Antibiotics Revenue (2021-2032) & (US$ Million) Table 156. U.K. Antibiotics Revenue (2021-2032) & (US$ Million) Table 157. Italy Antibiotics Revenue (2021-2032) & (US$ Million) Table 158. Netherlands Antibiotics Revenue (2021-2032) & (US$ Million) Table 159. China Antibiotics Revenue by Type (2021-2026) & (US$ Million) Table 160. China Antibiotics Revenue by Type (2027-2032) & (US$ Million) Table 161. China Antibiotics Sales by Type (2021-2026) & (K Units) Table 162. China Antibiotics Sales by Type (2027-2032) & (K Units) Table 163. China Antibiotics Sales Price by Type (2021-2026) & (US$/Unit) Table 164. China Antibiotics Sales Price by Type (2027-2032) & (US$/Unit) Table 165. China Antibiotics Revenue by Application (2021-2026) & (US$ Million) Table 166. China Antibiotics Revenue by Application (2027-2032) & (US$ Million) Table 167. China Antibiotics Sales by Application (2021-2026) & (K Units) Table 168. China Antibiotics Sales by Application (2027-2032) & (K Units) Table 169. China Antibiotics Sales Price by Application (2021-2026) & (US$/Unit) Table 170. China Antibiotics Sales Price by Application (2027-2032) & (US$/Unit) Table 171. Asia Antibiotics Revenue by Type (2021-2026) & (US$ Million) Table 172. Asia Antibiotics Revenue by Type (2027-2032) & (US$ Million) Table 173. Asia Antibiotics Sales by Type (2021-2026) & (K Units) Table 174. Asia Antibiotics Sales by Type (2027-2032) & (K Units) Table 175. Asia Antibiotics Sales Price by Type (2021-2026) & (US$/Unit) Table 176. Asia Antibiotics Sales Price by Type (2027-2032) & (US$/Unit) Table 177. Asia Antibiotics Revenue by Application (2021-2026) & (US$ Million) Table 178. Asia Antibiotics Revenue by Application (2027-2032) & (US$ Million) Table 179. Asia Antibiotics Sales by Application (2021-2026) & (K Units) Table 180. Asia Antibiotics Sales by Application (2027-2032) & (K Units) Table 181. Asia Antibiotics Sales Price by Application (2021-2026) & (US$/Unit) Table 182. Asia Antibiotics Sales Price by Application (2027-2032) & (US$/Unit) Table 183. Asia Antibiotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 184. Asia Antibiotics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 185. Asia Antibiotics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 186. Asia Antibiotics Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 187. Asia Antibiotics Sales by Country (2021-2026) & (K Units) Table 188. Asia Antibiotics Sales by Country (2027-2032) & (K Units) Table 189. Asia Antibiotics Sales Price by Country (2021-2026) & (US$/Unit) Table 190. Asia Antibiotics Sales Price by Country (2027-2032) & (US$/Unit) Table 191. Japan Antibiotics Revenue (2021-2032) & (US$ Million) Table 192. South Korea Antibiotics Revenue (2021-2032) & (US$ Million) Table 193. India Antibiotics Revenue (2021-2032) & (US$ Million) Table 194. Australia Antibiotics Revenue (2021-2032) & (US$ Million) Table 195. China Taiwan Antibiotics Revenue (2021-2032) & (US$ Million) Table 196. Southeast Asia Antibiotics Revenue (2021-2032) & (US$ Million) Table 197. SAMEA Antibiotics Revenue by Type (2021-2026) & (US$ Million) Table 198. SAMEA Antibiotics Revenue by Type (2027-2032) & (US$ Million) Table 199. SAMEA Antibiotics Sales by Type (2021-2026) & (K Units) Table 200. SAMEA Antibiotics Sales by Type (2027-2032) & (K Units) Table 201. SAMEA Antibiotics Sales Price by Type (2021-2026) & (US$/Unit) Table 202. SAMEA Antibiotics Sales Price by Type (2027-2032) & (US$/Unit) Table 203. SAMEA Antibiotics Revenue by Application (2021-2026) & (US$ Million) Table 204. SAMEA Antibiotics Revenue by Application (2027-2032) & (US$ Million) Table 205. SAMEA Antibiotics Sales by Application (2021-2026) & (K Units) Table 206. SAMEA Antibiotics Sales by Application (2027-2032) & (K Units) Table 207. SAMEA Antibiotics Sales Price by Application (2021-2026) & (US$/Unit) Table 208. SAMEA Antibiotics Sales Price by Application (2027-2032) & (US$/Unit) Table 209. SAMEA Antibiotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 210. SAMEA Antibiotics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 211. SAMEA Antibiotics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 212. SAMEA Antibiotics Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 213. SAMEA Antibiotics Sales by Country (2021-2026) & (K Units) Table 214. SAMEA Antibiotics Sales by Country (2027-2032) & (K Units) Table 215. SAMEA Antibiotics Sales Price by Country (2021-2026) & (US$/Unit) Table 216. SAMEA Antibiotics Sales Price by Country (2027-2032) & (US$/Unit) Table 217. Brazil Antibiotics Revenue (2021-2032) & (US$ Million) Table 218. Argentina Antibiotics Revenue (2021-2032) & (US$ Million) Table 219. Chile Antibiotics Revenue (2021-2032) & (US$ Million) Table 220. Colombia Antibiotics Revenue (2021-2032) & (US$ Million) Table 221. Peru Antibiotics Revenue (2021-2032) & (US$ Million) Table 222. Saudi Arabia Antibiotics Revenue (2021-2032) & (US$ Million) Table 223. Israel Antibiotics Revenue (2021-2032) & (US$ Million) Table 224. UAE Antibiotics Revenue (2021-2032) & (US$ Million) Table 225. Turkey Antibiotics Revenue (2021-2032) & (US$ Million) Table 226. Iran Antibiotics Revenue (2021-2032) & (US$ Million) Table 227. Egypt Antibiotics Revenue (2021-2032) & (US$ Million) Table 228. Key Raw Materials Table 229. Raw Materials Key Suppliers Table 230. Antibiotics Distributors List Table 231. Antibiotics Customers List Table 232. Research Programs/Design for This Report Table 233. Authors List of This Report Table 234. Secondary Sources Table 235. Primary Sources List of Figures Figure 1. Antibiotics Image Figure 2. Global Antibiotics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antibiotics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Cephalosporins Image Figure 5. Macrolides Image Figure 6. Sulfonamides Image Figure 7. Others Image Figure 8. Penicillins Image Figure 9. Aminoglycosides Image Figure 10. Tetracyclines Image Figure 11. Global Antibiotics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Antibiotics Market Size Share 2021 VS 2025 VS 2032 Figure 13. Poultry Image Figure 14. Livestock Image Figure 15. Other Image Figure 16. Global Antibiotics Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Antibiotics Revenue (2021-2032) & (US$ Million) Figure 18. Global Antibiotics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Antibiotics Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Antibiotics Revenue Market Share by Region (2021-2032) Figure 21. Global Antibiotics Sales (2021-2032) & (K Units) Figure 22. Global Antibiotics Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 23. Global Antibiotics Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Antibiotics Sales YoY (2021-2032) & (K Units) Figure 25. Europe Antibiotics Sales YoY (2021-2032) & (K Units) Figure 26. China Antibiotics Sales YoY (2021-2032) & (K Units) Figure 27. Asia (Excluding China) Antibiotics Sales YoY (2021-2032) & (K Units) Figure 28. South America, Middle East and Africa Antibiotics Sales YoY (2021-2032) & (K Units) Figure 29. Global Antibiotics Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Antibiotics Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Antibiotics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Antibiotics Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Antibiotics Revenue Market Share by Type (2021-2032) Figure 35. Global Antibiotics Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Antibiotics Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Antibiotics Sales Market Share by Type (2021-2032) Figure 38. Global Antibiotics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Antibiotics Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Antibiotics Revenue Market Share by Application (2021-2032) Figure 41. Global Antibiotics Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 42. Global Antibiotics Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Antibiotics Sales Market Share by Application (2021-2032) Figure 44. North America Antibiotics Revenue Share by Type (2021-2032) Figure 45. North America Antibiotics Sales Share by Type (2021-2032) Figure 46. North America Antibiotics Revenue Share by Application (2021-2032) Figure 47. North America Antibiotics Sales Share by Application (2021-2032) Figure 48. North America Antibiotics Revenue Share by Country (2021-2032) Figure 49. North America Antibiotics Sales Share by Country (2021-2032) Figure 50. Europe Antibiotics Revenue Share by Type (2021-2032) Figure 51. Europe Antibiotics Sales Share by Type (2021-2032) Figure 52. Europe Antibiotics Revenue Share by Application (2021-2032) Figure 53. Europe Antibiotics Sales Share by Application (2021-2032) Figure 54. Europe Antibiotics Revenue Share by Country (2021-2032) Figure 55. Europe Antibiotics Sales Share by Country (2021-2032) Figure 56. China Antibiotics Revenue Share by Type (2021-2032) Figure 57. China Antibiotics Sales Share by Type (2021-2032) Figure 58. China Antibiotics Revenue Share by Application (2021-2032) Figure 59. China Antibiotics Sales Share by Application (2021-2032) Figure 60. Asia Antibiotics Revenue Share by Type (2021-2032) Figure 61. Asia Antibiotics Sales Share by Type (2021-2032) Figure 62. Asia Antibiotics Revenue Share by Application (2021-2032) Figure 63. Asia Antibiotics Sales Share by Application (2021-2032) Figure 64. Asia Antibiotics Revenue Share by Country (2021-2032) Figure 65. Asia Antibiotics Sales Share by Country (2021-2032) Figure 66. SAMEA Antibiotics Revenue Share by Type (2021-2032) Figure 67. SAMEA Antibiotics Sales Share by Type (2021-2032) Figure 68. SAMEA Antibiotics Revenue Share by Application (2021-2032) Figure 69. SAMEA Antibiotics Sales Share by Application (2021-2032) Figure 70. SAMEA Antibiotics Revenue Share by Country (2021-2032) Figure 71. SAMEA Antibiotics Sales Share by Country (2021-2032) Figure 72. Antibiotics Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Antibiotics Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Cephalosporins
  • Macrolides
  • Sulfonamides
  • Others
  • Penicillins
  • Aminoglycosides
  • Tetracyclines
Applications
  • Poultry
  • Livestock
  • Other
Companies covered
  • Astellas Pharma
  • Bristol Myers Squibb Company
  • Janssen Pharmaceuticals
  • Bayer
  • GlaxoSmithKline
  • Pfizer
  • Eli Lilly and Company
  • Novartis
  • Sanofi
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Antibiotics Market by Type
  3. 1.2.1 Global Antibiotics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cephalosporins
  5. 1.2.3 Macrolides
  6. 1.2.4 Sulfonamides
  7. 1.2.5 Others
  8. 1.2.6 Penicillins
  9. 1.2.7 Aminoglycosides
  10. 1.2.8 Tetracyclines
  11. 1.3 Antibiotics Market by Application
  12. 1.3.1 Global Antibiotics Market Size by Application, 2021 VS 2025 VS 2032
  13. 1.3.2 Poultry
  14. 1.3.3 Livestock
  15. 1.3.4 Other
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Antibiotics Market Dynamics
  1. 2.1 Antibiotics Industry Trends
  2. 2.2 Antibiotics Industry Drivers
  3. 2.3 Antibiotics Industry Opportunities and Challenges
  4. 2.4 Antibiotics Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Antibiotics Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Antibiotics Revenue by Region
  3. 3.2.1 Global Antibiotics Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Antibiotics Revenue by Region (2021-2026)
  5. 3.2.3 Global Antibiotics Revenue by Region (2027-2032)
  6. 3.2.4 Global Antibiotics Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Antibiotics Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Antibiotics Sales by Region
  9. 3.4.1 Global Antibiotics Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Antibiotics Sales by Region (2021-2026)
  11. 3.4.3 Global Antibiotics Sales by Region (2027-2032)
  12. 3.4.4 Global Antibiotics Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Antibiotics Revenue by Manufacturers
  2. 4.1.1 Global Antibiotics Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Antibiotics Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Antibiotics Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Antibiotics Sales by Manufacturers
  6. 4.2.1 Global Antibiotics Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Antibiotics Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Antibiotics Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Antibiotics Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Antibiotics Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Antibiotics Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Antibiotics Manufacturers, Product Type & Application
  13. 4.7 Global Antibiotics Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Antibiotics Market CR5 and HHI
  16. 4.8.2 2025 Antibiotics Tier 1, Tier 2, and Tier 3
5 Antibiotics Market by Type
  1. 5.1 Global Antibiotics Revenue by Type
  2. 5.1.1 Global Antibiotics Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Antibiotics Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Antibiotics Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Antibiotics Sales by Type
  6. 5.2.1 Global Antibiotics Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Antibiotics Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Antibiotics Sales Market Share by Type (2021-2032)
  9. 5.3 Global Antibiotics Price by Type
6 Antibiotics Market by Application
  1. 6.1 Global Antibiotics Revenue by Application
  2. 6.1.1 Global Antibiotics Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Antibiotics Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Antibiotics Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Antibiotics Sales by Application
  6. 6.2.1 Global Antibiotics Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Antibiotics Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Antibiotics Sales Market Share by Application (2021-2032)
  9. 6.3 Global Antibiotics Price by Application
7 Company Profiles
  1. 7.1 Astellas Pharma
  2. 7.1.1 Astellas Pharma Company Information
  3. 7.1.2 Astellas Pharma Business Overview
  4. 7.1.3 Astellas Pharma Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Astellas Pharma Antibiotics Product Portfolio
  6. 7.1.5 Astellas Pharma Recent Developments
  7. 7.2 Bristol Myers Squibb Company
  8. 7.2.1 Bristol Myers Squibb Company Company Information
  9. 7.2.2 Bristol Myers Squibb Company Business Overview
  10. 7.2.3 Bristol Myers Squibb Company Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Bristol Myers Squibb Company Antibiotics Product Portfolio
  12. 7.2.5 Bristol Myers Squibb Company Recent Developments
  13. 7.3 Janssen Pharmaceuticals
  14. 7.3.1 Janssen Pharmaceuticals Company Information
  15. 7.3.2 Janssen Pharmaceuticals Business Overview
  16. 7.3.3 Janssen Pharmaceuticals Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Janssen Pharmaceuticals Antibiotics Product Portfolio
  18. 7.3.5 Janssen Pharmaceuticals Recent Developments
  19. 7.4 Bayer
  20. 7.4.1 Bayer Company Information
  21. 7.4.2 Bayer Business Overview
  22. 7.4.3 Bayer Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Bayer Antibiotics Product Portfolio
  24. 7.4.5 Bayer Recent Developments
  25. 7.5 GlaxoSmithKline
  26. 7.5.1 GlaxoSmithKline Company Information
  27. 7.5.2 GlaxoSmithKline Business Overview
  28. 7.5.3 GlaxoSmithKline Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 GlaxoSmithKline Antibiotics Product Portfolio
  30. 7.5.5 GlaxoSmithKline Recent Developments
  31. 7.6 Pfizer
  32. 7.6.1 Pfizer Company Information
  33. 7.6.2 Pfizer Business Overview
  34. 7.6.3 Pfizer Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Pfizer Antibiotics Product Portfolio
  36. 7.6.5 Pfizer Recent Developments
  37. 7.7 Eli Lilly and Company
  38. 7.7.1 Eli Lilly and Company Company Information
  39. 7.7.2 Eli Lilly and Company Business Overview
  40. 7.7.3 Eli Lilly and Company Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Eli Lilly and Company Antibiotics Product Portfolio
  42. 7.7.5 Eli Lilly and Company Recent Developments
  43. 7.8 Novartis
  44. 7.8.1 Novartis Company Information
  45. 7.8.2 Novartis Business Overview
  46. 7.8.3 Novartis Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Novartis Antibiotics Product Portfolio
  48. 7.8.5 Novartis Recent Developments
  49. 7.9 Sanofi
  50. 7.9.1 Sanofi Company Information
  51. 7.9.2 Sanofi Business Overview
  52. 7.9.3 Sanofi Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Sanofi Antibiotics Product Portfolio
  54. 7.9.5 Sanofi Recent Developments
  55. 7.10 Abbott
  56. 7.10.1 Abbott Company Information
  57. 7.10.2 Abbott Business Overview
  58. 7.10.3 Abbott Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Abbott Antibiotics Product Portfolio
  60. 7.10.5 Abbott Recent Developments
8 North America
  1. 8.1 North America Antibiotics Market Size by Type
  2. 8.1.1 North America Antibiotics Revenue by Type (2021-2032)
  3. 8.1.2 North America Antibiotics Sales by Type (2021-2032)
  4. 8.1.3 North America Antibiotics Price by Type (2021-2032)
  5. 8.2 North America Antibiotics Market Size by Application
  6. 8.2.1 North America Antibiotics Revenue by Application (2021-2032)
  7. 8.2.2 North America Antibiotics Sales by Application (2021-2032)
  8. 8.2.3 North America Antibiotics Price by Application (2021-2032)
  9. 8.3 North America Antibiotics Market Size by Country
  10. 8.3.1 North America Antibiotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Antibiotics Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Antibiotics Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Antibiotics Market Size by Type
  2. 9.1.1 Europe Antibiotics Revenue by Type (2021-2032)
  3. 9.1.2 Europe Antibiotics Sales by Type (2021-2032)
  4. 9.1.3 Europe Antibiotics Price by Type (2021-2032)
  5. 9.2 Europe Antibiotics Market Size by Application
  6. 9.2.1 Europe Antibiotics Revenue by Application (2021-2032)
  7. 9.2.2 Europe Antibiotics Sales by Application (2021-2032)
  8. 9.2.3 Europe Antibiotics Price by Application (2021-2032)
  9. 9.3 Europe Antibiotics Market Size by Country
  10. 9.3.1 Europe Antibiotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Antibiotics Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Antibiotics Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Antibiotics Market Size by Type
  2. 10.1.1 China Antibiotics Revenue by Type (2021-2032)
  3. 10.1.2 China Antibiotics Sales by Type (2021-2032)
  4. 10.1.3 China Antibiotics Price by Type (2021-2032)
  5. 10.2 China Antibiotics Market Size by Application
  6. 10.2.1 China Antibiotics Revenue by Application (2021-2032)
  7. 10.2.2 China Antibiotics Sales by Application (2021-2032)
  8. 10.2.3 China Antibiotics Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Antibiotics Market Size by Type
  2. 11.1.1 Asia Antibiotics Revenue by Type (2021-2032)
  3. 11.1.2 Asia Antibiotics Sales by Type (2021-2032)
  4. 11.1.3 Asia Antibiotics Price by Type (2021-2032)
  5. 11.2 Asia Antibiotics Market Size by Application
  6. 11.2.1 Asia Antibiotics Revenue by Application (2021-2032)
  7. 11.2.2 Asia Antibiotics Sales by Application (2021-2032)
  8. 11.2.3 Asia Antibiotics Price by Application (2021-2032)
  9. 11.3 Asia Antibiotics Market Size by Country
  10. 11.3.1 Asia Antibiotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Antibiotics Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Antibiotics Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Antibiotics Market Size by Type
  2. 12.1.1 SAMEA Antibiotics Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Antibiotics Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Antibiotics Price by Type (2021-2032)
  5. 12.2 SAMEA Antibiotics Market Size by Application
  6. 12.2.1 SAMEA Antibiotics Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Antibiotics Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Antibiotics Price by Application (2021-2032)
  9. 12.3 SAMEA Antibiotics Market Size by Country
  10. 12.3.1 SAMEA Antibiotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Antibiotics Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Antibiotics Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Antibiotics Value Chain Analysis
  2. 13.1.1 Antibiotics Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Antibiotics Production Mode & Process
  6. 13.2 Antibiotics Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Antibiotics Distributors
  9. 13.2.3 Antibiotics Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst